Physician profile
Krishan Kumar
NPI 1033171434
$1,924.07
in general payments reported to CMS, 2019-2025
8 companies · $75.89 in 2025
The $75.89 reported for 2025 was more than what a typical Pediatric Emergency Medicine (Emergency Medicine) provider received nationally (typical 2025 total: $57.68).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $239 · 2020: $124 · 2021: $618 · 2022: $743 · 2024: $125 · 2025: $75.89.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $201.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $200.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $873.83 | 2020-2024 | Breztri |
| Boston Scientific Corporation | $322.20 | 2021-2025 | Watchman Flx |
| Glaxosmithkline, LLC. | $246.95 | 2019-2022 | |
| Intuity Medical INC | $123.61 | 2022 | |
| Insmed, INC. | $121.34 | 2021 | |
| Mallinckrodt Hospital Products INC. | $119.42 | 2022 | |
| Janssen Pharmaceuticals, INC | $99.97 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Krishan Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.